Breakthrough research on pancreatic cancer
Posted: 30 September 2021 Amplia Therapeutics and The Garvan have released a scientific paper today, revealing breakthrough research that lowers pancreatic cancer’s resistance to chemotherapy by ‘priming’ cancer cells. The breakthrough Amplia is pleased to report the publication of a key…
Neo-Bionica appoints internationally recognised CEO and Chair
Posted 1 September 2021 Neo-Bionica, a joint venture between Bionics Institute and The University of Melbourne has announced the appointment of two extremely well credentialled individuals. Dr Ludovic Labat has been appointed as CEO while BioMelbourne Network’s own Lusia Guthrie has…
An update on the impact of COVID-19 on Researchers
Posted 10 August 2021 The presence of COVID-19 in our community has disrupted the lives of every single Australian. As the national voice of the health and medical research sector, Research Australia has committed to understanding the specific…
Johnson & Johnson Innovation announces extension of partnering office at Monash University
Date Posted – 15 July 2021 Victorian State Government extends financing of JJIPO@Monash for an additional two years Extension will further boost Victorian hub for researchers and early-stage companies to connect with industry experts and deliver novel healthcare…
Tax breaks tipped to trigger innovation boom
Dated Posted – 20 May 2021 The country’s innovation giants say tax breaks for profits generated on local intellectual property will nurture high-value, local jobs and foster new companies, despite Australia still offering significantly weaker incentives than countries…
Federal Budget 2021 – Welcome Initiatives
Date Posted – 12 May 2021 From our CEO, Jeff Malone GAICD on the new budget… This new budget outlines a number of very welcome initiatives including continued and consistent support for the R&D tax incentive and investment into Biotech…
SA accelerates local COVID vaccine development for mutant strains
Date Posted – 13 May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what’s anticipated to be the second line of…
Victoria announces $50m to fund mRNA COVID-19 vaccine production in Australia, paving way for Pfizer-style manufacturing
Date Posted – 21 April 2021 The Victorian government is providing $50 million to “kickstart” domestic manufacturing of mRNA vaccine technology. It will take at least 12 months for any of the vaccines to be made in Australia,…
First Patients Benefit from Victoria’s Non-Invasive Gamma Knife
Date Posted – 8 April 2021 The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational, with the first patients to receive the non-invasive radiosurgery sharing their experiences. The Gamma…
University of Sydney receives approval to start COVALIA, a Phase 1 Clinical trial of COVIGEN, a New COVID-19 Vaccine Candidate in Australia
Date Posted – 26 March 2021 Date Published – 22 March 2021 First needle-free DNA-based COVID-19 candidate vaccine to be tested in Australia in a phase 1 trial in healthy subjects aged 18 to 75 years old •…
Latest COVID-19 Advice for Offices
Date Posted – 25 March 2021 The relaxation of COVID settings this week reinforces the need for good record keeping. The Victorian Government announced on Tuesday that the 75 per cent cap on office workers will be removed…
Parliament passes casual employee definition and addresses casual employment uncertainty
Date Posted – 23 March 2021 Written by – Karl Luke and Bridget Nunn There has been significant press around the government’s agenda to reform large parts of the Fair Work regime, most of which failed in the Senate.…
